Glenmark Pharmaceuticals Inc., USA: Ezetimibe and Simvastatin Tablets,
Recall reason: Failed Impurities/Degradation Specifications: Out of Specification (OOS) for related substances test for Anhydro Simvastatin at the 06-month time point during long-term stability study.. Recalled by Glenmark Pharmaceuticals Inc., USA. Distribution: Nationwide USA and PR. Classification (Class III — minor violation). Affected lots/NDC/dates: Lot #: 17240195, Exp 01/31/2026.. Return the recalled medication to the pharmacy where you purchased it for a full refund of the purchase price.
📬 Get email alerts for new Product Recalls & Refunds
Free — we'll email you when new matching opportunities appear. No spam, unsubscribe anytime.
New here? Here's how Reward Opportunity works:
🔔 More Product Recalls & Refunds
Product recalls offering refunds, replacements, or repairs to consumers who purchased the item.
Browse all product recalls & refunds →Not just this one — find everything you qualify for
Our AI scans 8,000+ bounties, settlements, grants, recalls, and paid studies against your profile to rank what you can actually claim.
Get My Free Match Report